References
- Opelz G Dohler B Ruhenstroth A Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report Am J Transplant 2004 4 928 936 15147427
- Preiksaitis JK Brennan DC Fishman J Allen U Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation: final report Am J Transplant 2005 5 218 227 15643981
- Paya CV Razonable RR Cytomegalovirus infection after organ transplantation Transplant Infections 2nd ed Philadelphia, PA Lippincott, Williams and Wilkins 2003
- Rubin RH Cytomegalovirus infection in the organ transplant recipient: The end of the “silo hypothesis” Curr Opin Infect Dis 2007 20 399 407 17609600
- Kranz B Vester U Wingen AM Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection Pediatr Transplant 2008 12 474 478 18466436
- Hjelmesaeth J Muller F Jenssen T Rollag H Sagedal S Hartmann A Is there a link between cytomegalovirus infection and new-onset post transplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage Nephrol Dial Transplant 2005 20 2311 2315 16046502
- [No authors listed] Cytomegalovirus Am J Transplant 2004 4 Suppl 10 51 58
- Hodson EM Jones CA Webster AC Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials Lancet 2005 365 2105 2115 15964447
- Kalil AC Levitsky J Lyden E Stoner J Freifeld AG Metaanalysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients Ann Intern Med 2005 143 870 880 16365468
- Lowance D Neumayer HH Legendre CM International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation N Engl J Med 1999 340 1462 1470 10320384
- Doyle AM Warburton KM Goral S Blumberg E Grossman RA Bloom RD 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course Transplantation 2006 81 1106 1111 16641594
- Zamora MR Nicolls MR Hodges TN Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation Am J Transplant 2004 4 1635 1642 15367218
- Valentine VG Weill D Gupta MR Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis J Heart Lung Tranplant 2008 8 27 8; 875 81
- Schnitzler MA Lowell JA Hmiel SP Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching J Am Soc Nephrol 2003 14 780 785 12595516
- Delgado JF Manito N Almenar L Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study Transpl Infect Dis 2011 13 136 144 21040280
- Limaye AP Corey L Koelle DM Davis CL Boeckh M Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants Lancet 2000 356 645 649 10968438
- Landry ML Ferguson D Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease J Clin Microbiol 1993 31 2851 2856 8263166
- Wagner HJ Fischer L Jabs WJ Holbe M Pethig K Bucsky P Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction Transplantation 2002 74 656 664 12352882
- Koch A Daniel V Dengler TJ Schnabel PA Hagl S Sack FU Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat) J Heart Lung Transplant 2005 24 708 713 15949731
- Hodson EM Craig JC Strippoli GF Webster AC Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients Cochrane Database Syst Rev 2008 2 CD003774 18425894
- Humar A Lebranchu Y Vincenti F The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients Am J Transplant 2010 10 1228 1237 20353469
- Kotton CN Kumar D Caliendo AM International consensus guidelines on the management of cytomegalovirus in solid organ transplantation Transplantation 2010 89 779 795 20224515